Shu‐Hui Liu
- Molecular Biology
- Oncology top 10%
- Immunology top 10%
- Radiology, Nuclear Medicine and Imaging top 5%
- Cell Biology top 10%
- Co-authors
- Frances M. BrodskyHaifeng YuB. Matija PeterlinXiaobin LüMei Lie WongCharles S. CraikArvind RajpalPavel Strop
- Topics
- Monoclonal and Polyclonal Antibodies Research (11 papers)HER2/EGFR in Cancer Research (6 papers)Immunotherapy and Immune Responses (5 papers)
- Cited by
- VirologyOncologyImmunology
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Shu‐Hui Liu
47 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 109
- Molecular Biology 471
- Oncology 435
- Immunology 291
- Radiology, Nuclear Medicine and Imaging 276
- Cell Biology 164
Countries citing papers authored by Shu‐Hui Liu
This map shows the geographic impact of Shu‐Hui Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Hui Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Hui Liu more than expected).
Fields of papers citing papers by Shu‐Hui Liu
This network shows the impact of papers produced by Shu‐Hui Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Hui Liu. The network helps show where Shu‐Hui Liu may publish in the future.
Co-authorship network of co-authors of Shu‐Hui Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Shu‐Hui Liu. A scholar is included among the top collaborators of Shu‐Hui Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu‐Hui Liu. Shu‐Hui Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 12 | |
| 7 | 1 | |
| 8 | 10 | |
| 9 | 3 | |
| 10 | 14 | |
| 11 | 0 | |
| 12 | 42 | |
| 13 | 49 | |
| 14 | 7 | |
| 15 | 78 | |
| 16 | 162 | |
| 17 | 14 | |
| 18 | A novel splice variant of human Ep-CAM as a potential therapeutic antibody target for epithelial cell-based cancers | 1 |
| 19 | 218 | |
| 20 | 133 |
About Shu‐Hui Liu
Shu‐Hui Liu is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 53 papers that have together received 1.2k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (11 papers), HER2/EGFR in Cancer Research (6 papers) and Immunotherapy and Immune Responses (5 papers). The work is most often cited by research in Virology (141 citations), Oncology (435 citations) and Immunology (291 citations). Shu‐Hui Liu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Frances M. Brodsky, Haifeng Yu, B. Matija Peterlin, Xiaobin Lü, Mei Lie Wong, Charles S. Craik, Arvind Rajpal, Pavel Strop, Kathy Delaria and Russell G. Dushin. Their work appears in journals such as Cell, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.